Clinical Trials
3 trialsNCT07256015 2025-12-01
Deucravacitinib for Patients With Moderate/Severe Psoriasis: A Real-Life Experience in Italy
Bristol-Myers Squibb
Recruiting
NCT06952465 2025-05-01
A Study Comparing the Risk of Serious Infections and Malignancies With Deucravacitinib or Biologics in Japanese Patients With Psoriasis
Bristol-Myers Squibb
Active not recruiting
NCT06281106 2025-04-02
TYPP
Centre Hospitalier Universitaire Vaudois
Phase 2/3 Terminated